Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — Clinical trial policy ...

Palmer is investigating how telehealth is driving the consumerization of drugs. This is Part 6 of the series The VirtualRx Boom. Katie covers the impact of health technology on patients, clinicians, ...

What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...

AstraZeneca agreed to pay $34 million to settle claims that the company paid kickbacks to improperly influence prescriptions ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Isabella is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. You can reach her on Signal at isabellacueto.03. WASHINGTON — A ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.